European journal of applied physiology · 2026
Effect of sodium bicarbonate on performance and markers of kidney and gastrointestinal injury during repeated sprints in the heat.
СтатьяРандомизированное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Specht Jonathan W, Ramirez Marissa, Raef Jennifer, Schwartz Mackenzie, Bailly Alyssa R, Chavez Oscar, Kumbasar Ozan, Dawson Jade X, Apodaca Jessica, Freire Raul, Atkins Whitley C, de Castro Magalhães Flávio, Siegler Jason, Amorim Fabiano T
Аннотация
PURPOSE: We tested the hypotheses that sodium bicarbonate (SB) supplementation improves performance, reduces markers of acute kidney injury (AKI) risk, and increases markers of acute gastrointestinal injury (AGI) during repeated sprints in the heat.
METHODS: Using a double-blind design, 10 recreationally endurance-trained participants ingested 0.2 g/kg of body weight of SB or placebo before cycling in the heat (dry-bulb: 40 °C, relative humidity: 20%). Exercise bouts included a 22-min warm-up, then 4-sets of 5 × 6-sec maximal-effort standing cycling sprints. Core temperature (Tc) was measured at baseline, end of warm-up, after set two of sprints, and post-exercise bouts. Urine and plasma collected pre-ingestion and pre-, post-, and 1-h post-exercise were analyzed for markers of AKI risk, AGI, and endotoxemia.
RESULTS: SB increased peak (average difference between conditions: 21 ± 11 W, condition effect: p = 0.02) and average (p = 0.03) power across the sprints. Tc increased from pre- to post-exercise (placebo: Δ1.3 ± 0.3 °C, SB: Δ1.4 ± 0.4 °C, time effect: p < 0.001), but there were no effects of condition or interaction. Exercise increased the primary marker of AKI (urinary IGFBP7×TIMP-2, time effect: p = 0.005) but not urinary NGAL. There were no condition or interaction effects for either AKI marker. Plasma I-FABP, a marker of AGI, increased post-exercise bouts (placebo: Δ291 ± 550 pg/mL, SB: Δ397 ± 482 pg/mL, p = 0.03), with no condition or interaction effects. There were no significant effects for markers of endotoxemia (LBP, sCD14).
CONCLUSIONS: SB supplementation improves repeat sprint performance in the heat without altering Tc, markers of AKI risk, or markers of AGI.
METHODS: Using a double-blind design, 10 recreationally endurance-trained participants ingested 0.2 g/kg of body weight of SB or placebo before cycling in the heat (dry-bulb: 40 °C, relative humidity: 20%). Exercise bouts included a 22-min warm-up, then 4-sets of 5 × 6-sec maximal-effort standing cycling sprints. Core temperature (Tc) was measured at baseline, end of warm-up, after set two of sprints, and post-exercise bouts. Urine and plasma collected pre-ingestion and pre-, post-, and 1-h post-exercise were analyzed for markers of AKI risk, AGI, and endotoxemia.
RESULTS: SB increased peak (average difference between conditions: 21 ± 11 W, condition effect: p = 0.02) and average (p = 0.03) power across the sprints. Tc increased from pre- to post-exercise (placebo: Δ1.3 ± 0.3 °C, SB: Δ1.4 ± 0.4 °C, time effect: p < 0.001), but there were no effects of condition or interaction. Exercise increased the primary marker of AKI (urinary IGFBP7×TIMP-2, time effect: p = 0.005) but not urinary NGAL. There were no condition or interaction effects for either AKI marker. Plasma I-FABP, a marker of AGI, increased post-exercise bouts (placebo: Δ291 ± 550 pg/mL, SB: Δ397 ± 482 pg/mL, p = 0.03), with no condition or interaction effects. There were no significant effects for markers of endotoxemia (LBP, sCD14).
CONCLUSIONS: SB supplementation improves repeat sprint performance in the heat without altering Tc, markers of AKI risk, or markers of AGI.